Clinical Trial Update: Suberoylanilide Hydroxamic Acid, Fluorouracil, Leucovorin, and Oxaliplatin in Treating Patients With Progressive Metastatic or Unresectable Colorectal Cancer or Other Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a combination of vorinostat (suberoylanilide hydroxamic acid) with fluorouracil, leucovorin, and oxaliplatin in patients with progressi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• Eloxatin (oxaliplatin)
• FLUOROURACIL (Fluorouracil)
• Leucovorin (folinic acid)
• Zolinza (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Colon Cancer, Recurrent Rectal Cancer | Phase 1 | Status: COMPLETED